Ledger.Open graph →
SEC Form D · filed January 7, 2025

Rila Therapeutics, Inc

Offering
$10.8M
Sold
$7.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
SOUTH SAN FRANCISCO, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (6)

Michael Hui · South San Francisco, CADirectorRobert Drakas · South San Francisco, CAExec · DirectorWilliam Dai · Palo Alto, CADirectorRobert Drakas · South San Francisco, CAExec · DirectorMichael Hui · South San Francisco, CADirectorWilliam Dai · Palo Alto, CADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗